Skip to Main Content
Contribute Try STAT+ Today

Over the past seven years, a top editor at a medical journal devoted to obesity research received $1.2 million from companies that sold or were developing prescription weight-loss treatments, raising concerns about how potential conflicts of interest among those with especially influential roles in academic publishing are treated.

During that time, Obesity associate editor-in-chief Donna Ryan co-authored a paper describing the added benefits of a diabetes treatment sold by a company that paid her the bulk of those fees. The same company paid a communications firm to provide writing assistance. She also co-authored an editorial praising the pricing approach taken by a manufacturer with which she had a financial relationship, although the effectiveness of the diet drug was modest. Unlike the paper, the editorial did not disclose her ties.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment